NCT02208934
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
- Locations
-
- CIM-Sant Pau - IIB Sant Pau, HSCSP Barcelona, Spain
- Palobiofarma S.L. (molecule owner) Mataró, Barcelona, Spain
Clinical trial condition
Explore clinical trials studying Basal Ganglia Diseases. Study availability and eligibility vary by location and protocol.
NCT02208934
NCT02701621
NCT01691924
NCT01119131
NCT00736671
NCT01956032
Not specified
NCT02619084
NCT02606682
NCT02680522
NCT01381302